Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04092439 · ClinicalTrials.gov registry record · NA
The Effects of Watermelon Juice Supplementation on Postprandial Vascular Endothelial Function
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04092439: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT04092439 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04092439, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to test if watermelon juice supplementation improves vascular dysfunction experience during hyperglycemia.
Primary Outcome
Flow mediated dilation
Interventions
- DIETARY_SUPPLEMENT Watermelon Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-09-12 |
| Est. Completion | 2020-03-20 |
| Phase | NA |
What the finished NCT04092439 record still lists
NCT04092439 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Watermelon Juice is the first listed.
NCT04092439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04092439 about?
NCT04092439 is a clinical study titled "The Effects of Watermelon Juice Supplementation on Postprandial Vascular Endothelial Function". The purpose of this study is to test if watermelon juice supplementation improves vascular dysfunction experience during hyperglycemia.
What is the current status of trial NCT04092439?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-09-12. Estimated completion is 2020-03-20.
What interventions are being tested in trial NCT04092439?
The interventions under investigation include: Watermelon Juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04092439?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04092439's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI